Brr Op Co, LLC Abb Vie Inc. Transaction History

Brr Op Co, LLC

$815 Million
Q3 2022

A detailed history of Brr Op Co, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Brr Op Co, LLC holds 26,737 shares of ABBV stock, worth $4.81 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

26,737

Previous 19,046 40.38%

Holding current value

$4.81 Million

Previous $2.92 Million 23.0%

% of portfolio

0.44%

Previous 0.35%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $1.03 Million - $1.18 Million	7,691 Added 40.38%	26,737 $3.59 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $89,315 - $113,549	649 Added 3.53%	19,046 $2.92 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $224,102 - $278,047	-1,698 Reduced 8.45%	18,397 $2.98 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $71,226 - $90,121	663 Added 3.41%	20,095 $2.72 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $72,671 - $82,492	683 Added 3.64%	19,432 $2.1 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $11,047 - $12,307	-105 Reduced 0.56%	18,749 $2.11 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $70,177 - $77,257	-686 Reduced 3.51%	18,854 $2.04 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $131,842 - $178,001	1,638 Added 9.15%	19,540 $2.09 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $11,769 - $13,813	-137 Reduced 0.76%	17,902 $1.57 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $57,522 - $76,973	784 Added 4.54%	18,039 $1.77 Million
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $78,238 - $118,619	1,213 Added 7.56%	17,255 $1.32 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $840,170 - $1.05 Million	11,648 Added 265.09%	16,042 $1.42 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $12,784 - $15,371	203 Added 4.84%	4,394 $333,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $1,248 - $1,595	19 Added 0.46%	4,191 $305,000
Q1 2019 Apr 26, 2019	BUY	$77.14 - $90.79 $62,020 - $72,995	804 Added 23.87%	4,172 $336,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $5,138 - $6,336	66 Added 2.0%	3,368 $311,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $30,673 - $34,099	-345 Reduced 9.46%	3,302 $312,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $38,874 - $45,997	433 Added 13.47%	3,647 $338,000
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $49,501 - $66,286	538 Added 20.1%	3,214 $304,000
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $52,392 - $57,452	-585 Reduced 17.94%	2,676 $259,000
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $227,780 - $290,946	3,261	3,261 $289,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brr Op Co, LLC with notifications on news.

Account